Hyeongseon Jeon

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Acute Lymphoblastic Leukemia

Top Venues

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea M Peterson, Yi Wang, Kelsi Reynolds, Robert Bolz, Jessica Miao, Chunhua Song, Dayong Wu, Wing Keung Chan, Evandro D Bezerra, Narendranath Epperla, Timothy J Voorhees, Jonathan E Brammer, Adam S Kittai, David A Bond, Yazeed Sawalha, Audrey M Sigmund, John C Reneau, Mark P Rubinstein, Walter Hanel, Beth Christian, Robert A Baiocchi, Kami J Maddocks, Lapo Alinari, Sumithira Vasu, Marcos J deLima, Dongjun Chung, Samantha M Jaglowski, Zihai Li, Xiaopei Huang, Yiping Yang
Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma. Blood advances (2024)
Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea M Peterson, Yi Wang, Kelsi Reynolds, Robert M Bolz, Jessica Miao, Chunhua Song, Dayong Wu, Wing Keung Chan, Evandro D Bezerra, Narendranath Epperla, Timothy J Voorhees, Jonathan Brammer, Adam S Kittai, David A Bond, Yazeed Sawalha, Audrey M Sigmund, John C Reneau, Mark P Rubinstein, Walter Hanel, Beth Christian, Robert A Baiocchi, Kami Maddocks, Lapo Alinari, Sumithira Vasu, Marcos J deLima, Dongjun Chung, Samantha M Jaglowski, Zihai Li, Xiaopei Huang, Yiping Yang
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma. Blood advances 8 (12) (2024)
Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea M Peterson, Yi Wang, Kelsi Reynolds, Robert M Bolz, Jessica Miao, Chunhua Song, Dayong Wu, Wing Keung Chan, Evandro D Bezerra, Narendranath Epperla, Timothy J Voorhees, Jonathan Brammer, Adam S Kittai, David A Bond, Yazeed Sawalha, Audrey M Sigmund, John C Reneau, Mark P Rubinstein, Walter Hanel, Beth Christian, Robert A Baiocchi, Kami Maddocks, Lapo Alinari, Sumithira Vasu, Marcos J deLima, Dongjun Chung, Samantha M Jaglowski, Zihai Li, Xiaopei Huang, Yiping Yang
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma. Blood advances 8 (12) (2024)
Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea M Peterson, Yi Wang, Kelsi Reynolds, Robert M Bolz, Jessica Miao, Chunhua Song, Dayong Wu, Wing Keung Chan, Evandro D Bezerra, Narendranath Epperla, Timothy J Voorhees, Jonathan Brammer, Adam S Kittai, David A Bond, Yazeed Sawalha, Audrey M Sigmund, John C Reneau, Mark P Rubinstein, Walter Hanel, Beth Christian, Robert A Baiocchi, Kami Maddocks, Lapo Alinari, Sumithira Vasu, Marcos J deLima, Dongjun Chung, Samantha M Jaglowski, Zihai Li, Xiaopei Huang, Yiping Yang
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma. Blood advances 8 (12) (2024)
Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea M Peterson, Yi Wang, Kelsi Reynolds, Robert M Bolz, Jessica Miao, Chunhua Song, Dayong Wu, Wing Keung Chan, Evandro D Bezerra, Narendranath Epperla, Timothy J Voorhees, Jonathan Brammer, Adam S Kittai, David A Bond, Yazeed Sawalha, Audrey M Sigmund, John C Reneau, Mark P Rubinstein, Walter Hanel, Beth Christian, Robert A Baiocchi, Kami Maddocks, Lapo Alinari, Sumithira Vasu, Marcos J deLima, Dongjun Chung, Samantha M Jaglowski, Zihai Li, Xiaopei Huang, Yiping Yang
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma. Blood advances 8 (12) (2024)
Himanshu Savardekar, Carter Allen, Hyeongseon Jeon, Jianying Li, Dionisia Quiroga, Emily Schwarz, Richard C Wu, Sara Zelinskas, Gabriella Lapurga, Alexander Abreo, Andrew Stiff, Jami Shaffer, Bradley W Blaser, Matthew Old, Robert Wesolowski, Gang Xin, Kari L Kendra, Dongjun Chung, William E Carson
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase. Molecular cancer research : MCR (2023)